113
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee

&
Pages 336-341 | Accepted 28 Mar 2003, Published online: 22 Sep 2008

References

  • Glaser K, Sung ML, O’Neil K, Belfast M, Hartman D, Carlson R, Kreft A, Kubrak D, Hsiao CL, Weichman B. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. Eur J Pharmacol 1995;281: 107–11
  • Freitas GG. A double-blind comparison of etodolac and piroxicam in the treatment of osteoarthritis. Curr Med Res Opin 1990;12:255–62
  • Grisanti AM, Lopes Vaz AA, Samara AM. Comparison of etodolac and diclofenac in osteoarthritis of the knee. Clin Ther 1992;14:791–800
  • Neustadt DH. Double blind evaluation of the long-term effects of etodolac versus ibuprofen in patients with rheumatoid arthritis. J Rheumatol 1997;Suppl 47:17–22
  • Porzio F. Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee. Rheumatol Int 1993;13:S19–24
  • Paulsen GA, Baigun S, Galvao de Figueiredo J, Gomes de Freitas G. Efficacy and tolerability comparison of etodolac and piroxicam in the treatment of patients with osteoarthritis of the knee. Curr Med Res Opin 1991;12:401–12
  • Schattenkirchner M. The safety profile of sustained-release etodolac. Rheumatol Int 1993;13:S31–35
  • Khan FM, Williams PI. Double-blind comparison of etodolac SR and diclofenac SR in the treatment of patients with degenerative joint disease of the knee. Curr Med Res Opin 1992;13:1–12
  • Bacon P. Worldwide experience with etodolac (Lodine®) 300 mg b.i.d. in the treatment of osteoarthritis. Rheumatol Int 1993;13:S7–12
  • Lonauer G, Tisscher JR, Lim HG, Bijlsma JWJ. Double-blind comparison of etodolac and diclofenac in patients with rheumatoid arthritis. Curr Med Res Opin 1993;13:70–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.